Hospital Universitario

Madrid 28222

1 studies enrolling now · 3 studies all time

What they study most

EPP, Severe Hypertriglyceridemia, Small Cell Lung Cancer, XLP

Studies at this site

• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) — Recruiting now
• A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia — Completed
• A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer — Stopped early